Yuhan report

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Full financial report of Yuhan

   KRW per share 
 Price  217,500.00
 Dividend  1,914.00
 Earnings  9,797.30
 Cash-flow  11,328.13
 Book value  145,000.00
 Equity  139,961.43

Yuhan is a company from Korea specialized in Pharmaceuticals and Biotechnology sector, which is part of Health Care industry. Yuhan shares are publicly traded at Korea stock exchange.

On the date of this report, Yuhan shares trade at 217,500.00 KRW after descending their price a -7.20% last year.

The equity of Yuhan is composed by 11 million shares. The company has a free float of 74.4% from total capizatilation. Finally, Yuhan capitalizacion (equity market value) is 2,392,500 million KRW.

Some of the main competitors of Yuhan within the Pharmaceuticals and Biotechnology sector are: Dr Reddys Labs, Suzuken, Celgene Corp, Alexion Pharm, Richter, Kobayashi Pharmaceut, Celltrion Healthcare, Aspen Pharmacare Hol, Hisamitsu Pharmaceut, Takeda Pharm, Bioverativ, Shanghai Fosun Pharm, ...

   PER   P/BV   P/CF   ROE   Div.Y   Payout 
Yuhan 22.20 1.50 19.20 7.00% 0.88% 19.54%
Global 17.55 3.23 12.70 15.62% 2.64% 38.56%
Korea 14.38 1.93 7.19 10.21% 1.86% 21.57%
Health Care 24.20 5.68 20.56 17.44% 1.27% 25.52%
Pharmaceuticals and Biotechnology 22.38 5.80 18.69 16.41% 1.38% 27.34%

Next, we analize Yuhan financial situation on the basis of accounting information from Dec 17. We will compare several multipliers and ratios of Yuhan with the average of the world, other companies from Korea, its industry "Health Care", and finally in its sector "Health Care". That way we can know if the company is over or undervalued.

Finally, last month performance of Yuhan shows a -8.60% return compared to a -1.61% of the hole stock market. Over the last year, the company has performed a -7.20% versus a market return of a 7.26%.

The following graph compares the performance of Yuhan with the return obtained by Korea, Health Care and Pharmaceuticals and Biotechnology companies, both for last month and last year. Here can be appreciated that Yuhan has obtained a lower return than both the market and other firms of the Health Care industry, which have obtained a return of 7.26% and 15.50% respectevely.

Yuhan compared stock return

Next companies

Yulon Motor Co.. Taiwan. Consumer Goods.

Yulon Nissan Motor C. Taiwan. Consumer Goods.

Yum Brands. USA. Consumer Services.

Yum China Holdings. USA. Consumer Services.

YY ADS (N Shares). China. Technology.

Zalando SE. Germany. Consumer Services.

Previous companies

Yuexiu Property (Red. China. Financials.

Yue Yuen Industrial. Hong-Kong. Consumer Goods.

Yuanta Financial Hol. Taiwan. Financials.

YTL Power Internl. Malaysia. Utilities.

YTL Corp. Malaysia. Utilities.

Yokohama Rubber. Japan. Consumer Goods.

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.